Celldex Therapeutics Stock Quote CLDX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

42.83

Bid

42.79

Ask

42.91

Volume

349,084

42.67 Day's Range 45.15

22.11 52 Week Range 53.18

Market Cap

2.839B

Previous Close

43.76

Open

44.00

Last Trade

42.802

Last Trade Time

13:35:00

Financial Volume

$ 15,327,391

VWAP

43.9075

Average Volume (3m)

715,888

Shares Outstanding

66,287,596

Dividend Yield

PE Ratio

-20.08

Earnings Per Share (EPS)

-2.13

Revenue

6.88M

Net Profit

-141.43M

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.celldex.com

Headquarters

Wilmington, Delaware, USA

Founded

Celldex Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CLDX. The last closing price for Celldex Therapeutics was $43.76. Over the last year, Celldex Therapeutics shares have traded in a share price range of $ 22.11 to $ 53.18.

Celldex Therapeutics currently has 66,287,596 shares outstanding. The market capitalization of Celldex Therapeutics is $2.90 billion. Celldex Therapeutics has a price to earnings ratio (PE ratio) of -20.08.

Overall Flow

Bearish

Net Premium

-280k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

FeaturedElement79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.49	3.60425737784	41.34	45.15	40.52	848432	43.15752409	CS
4	9.7	29.2785994567	33.13	45.15	31.4	655195	37.87696592	CS
12	8.33	24.1449275362	34.5	46.86	31.4	715888	37.58728204	CS
26	-4.67	-9.83157894737	47.5	48.365	31.4	699983	38.48131679	CS
52	14.06	48.8703510601	28.77	53.18	22.11	753972	36.83226071	CS
156	-12.31	-22.3249909322	55.14	57.2	19.85	618405	35.52011497	CS
260	40.71	1920.28301887	2.12	57.2	1.5	694830	26.37695961	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SINTSiNtx Technologies Inc	$ 5.1076 (81.12%)	61.83M
RLAYRelay Therapeutics Inc	$ 9.995 (60.18%)	13.63M
NBSTWNewbury Street Acquisition Corporation	$ 0.08 (59.05%)	9.4k
SMMTSummit Therapeutics Inc	$ 19.40 (58.11%)	37.41M
TILInstill Bio Inc	$ 20.83 (46.18%)	969.53k
EGIOEdgio Inc	$ 1.18 (-80.88%)	3.83M
PEGYPineapple Energy Inc	$ 0.2914 (-64.00%)	8.92M
TOIIWOncology Institute Inc	$ 0.0102 (-36.25%)	49.89k
TCBPTC BioPharm Holdings PLC	$ 5.55 (-29.30%)	276.53k
CACOCaravelle International Group	$ 0.2776 (-27.16%)	400.06k
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.1691 (18.67%)	211.77M
WTOUTime Limited	$ 0.0486 (-26.36%)	193.66M
NVDANVIDIA Corporation	$ 105.9193 (3.00%)	174.57M
SQQQProShares UltraPro Short QQQ	$ 9.3301 (-4.01%)	109.76M
INBSIntelligent Bio Solutions Inc	$ 2.20 (39.24%)	80.8M